🏛️ The Life-Saving Medicine Dilemma

🌟 Imagine a revolutionary new drug that could save millions of lives. Amazing, right? But here's the catch - what if only the wealthy can afford it? This episode explores how patent law tries to balance rewarding innovation while ensuring public benefit through two fascinating Indian court cases.

💡 What You'll Discover:

• 🔍 Why you can't challenge a patent in multiple courts simultaneously (and what happens if you try)
• ⚖️ How compulsory licensing works when medicines are too expensive for common people
• 🎯 The strategic chess game of patent litigation - choosing the right legal door matters
• 💊 Why 'working the patent in India' means more than just importing and selling

🚀 Real Cases Discussed:

• 💎 Dr. Aloys Wobben vs. Yogesh Mehra - The wind energy patent case that clarified you can't have your cake and eat it too in patent challenges
• ⭐ Bayer Corporation vs. Government of India - The Nexavar cancer drug case where public health trumped patent profits

🎙️ From wind turbines to cancer treatments, discover how Indian courts are reshaping the balance between innovation rewards and public access - and what this means for the future of AI and gene editing patents!